reports
- Wim Hoste
Akzo Nobel FIRST LOOK: 4Q EBITDA -4%, FY26 guidance slightly below exp...
4Q adjusted EBITDA dropped by 4% y/y and was in line with our forecast while being 2% below consensus. Akzo guides for a FY26 adj EBITDA at or above € 1.47bn, which is at the low end 2% below our forecast and 4% below consensus. The merger with Axalta is expected to close in late 2026 or early 2027. Taking into account the volatile track record and low structural growth, we maintain our Hold rating and € 65 target price.
- Wim Hoste
Titan Completion of acquisition of Vracs de L'Estuaire
Titan has completed the earlier announced acquisition of the cementitious business of Vracs de l'Estuaire. The acquisition complements Titan's European footprint and also fits well within TITAN's Forward 2029 Strategic plan which was presented in November 2025, and which targets to grow EBITDA by 62% to € 1bn by 2029 on a combination of organic growth initiatives and M&A in regions where the company has an established footprint and acquisitions offer sizeable synergies potential. Overall, TITAN ...
- Hilde Van Boxstael
- Jacob Mekhael
- Wim Hoste
- Wim Lewi
- Jacob Mekhael
UCB Kygevvi receives positive CHMP opinion in ultra-rare disease TK2d
Friday during trading hours, UCB announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the granting of marketing authorisation under exceptional circumstances for Kygevvi (doxecitine and doxribtimine) for the treatment of pediatric and adult patients with genetically confirmed thymidine kinase 2 deficiency (TK2d) with an age of symptom onset on or before 12 years. Following the positive CHMP opinion...
- Hilde Van Boxstael
- Livio Luyten
- Michiel Declercq
- Thomas Couvreur
- Wim Lewi
- Wim Lewi
Warehouses De Pauw FY25 Results in line, BLEND30 guides for +6% EPS gr...
WDP initiated “BLEND30” strategy with €2.00 EPRA EPS by FY30 at +6% growth yoy. Capex is mainly internally sourced and “gradual” entry in Spain and Italy. FY25 EPRA EPS came in line with their €1.53 guidance and our expectation of €1.54. EPRA EPS yoy growth of 2.3% is still impressive due to the abolition of the Dutch FBI regime. WDP estimates its underlying EPS growth at 7%. Current development pipeline stands at 480k sqm of which 81% is pre-let with an expected NOI yield of 7.3%. The high pre...
- Hilde Van Boxstael
- Lynn Hautekeete
- Thomas Couvreur
- Wim Hoste
- Thibault Leneeuw
ASML Strong order intake and better than expected FY26 outlook
ASML reported very strong order intake in 4Q25, 89% above CSS expectations. This was supported by robust demand from AI. Revenue and gross profit were slightly higher than expected, while net income was slightly below expectations. The focus will be on the strong order intake driven by AI demand and the improved outlook for 2026. ASML expects FY26 revenues of € 34-39bn, which at the midpoint is 3.5% above VA CSS. However, for FY27 we see limited upside due to bullish estimates and roadmaps. We b...
- Livio Luyten
- Michiel Declercq
- Thibault Leneeuw
- Wim Hoste
- Wim Hoste
Solvay Taking a more cautious stance, lowering target price
Increased pressure in the soda ash market prompts us to take a more conservative approach with regards to contract terms for the coming years, resulting in a reduction of our group EBITDA forecasts for 2026-2028 by between 6-11%. The dividend policy of a stable to increasing dividend from a € 2.43 base looks increasingly generous as servicing the dividend representing the vast majority of current FCF generation, limiting the group's ability to pursue other growth initiatives. Despite the attract...
- Michiel Declercq
Philips Ready to Start from a Clean Sheet
Running up to the CMD on 10 February, we initiate coverage on Philips with an Accumulate rating and a €27.5 TP. While we see potential for the company to positively surprise with its 2028 margin ambitions, investors will likely focus on the phasing, as 2026 margins will still be held back by tariff normalization. Nevertheless, with the majority of Respironics-related uncertainty now behind us, we believe Philips has room to increase shareholder returns and potentially announce a new share buybac...
- Wim Hoste
Bekaert FIRST LOOK:Acquiring Bridgestone Chinese/Thai tire cord activi...
Bekaert's € 60m acquisition of Bridgestone's captive tire cord business in Thailand and China fits within a long track record of similar acquisitions and further strengthens Bekaert's relationship with Bridgestone, one of the leading global tire makers. With a net debt/EBITDA of only 0.7x, Bekaert can easily fund this acquisition. In general, management has been looking at M&A to accelerate growth, although sizeable M&A is having a tough time to compete against share buybacks in terms of attract...
- Kristof Samoy
Ekopak Partnership with unnamed infrastructure partner for WaaS develo...
Ekopak just announced a long term strategic partnership with an unnamed European infrastructure partner for the development of (large) WaaS projects. Many details are still unknown and management was not (yet) available for comments. The partnership introduces a minimum of €150m in off balance sheet funding over the next three years that will be deployed through dedicated asset companies financed with senior non recourse debt and majority equity from the infrastructure partner. As part of the pa...
- Guy Sips
- Kristof Samoy
- Livio Luyten
- Lynn Hautekeete
- Michiel Declercq
- Wim Lewi
- Kristof Samoy
Fugro Hamburg declaration on new OFW investment pact and FY25 preview
Yesterday at a North Sea summit the Hamburg Declaration was signed by energy ministers from Belgium, Denmark, France, Germany, Ireland, Luxembourg, the Netherlands, Norway and the United Kingdom with Iceland joining as an observer. The governments agreed to work towards up to 100 GW of cross-border offshore wind capacity in the North Seas by 2050, while also advancing offshore renewable hydrogen as part of a more integrated regional energy system European governments committed to derisking offsh...
- Wim Lewi
Elia Group AI investment tsunami whips up TSO valuations
We upgrade our recommendation to Accumulate and raise our price target to €135.0 from €110.0 on multiple expansion over the next 6 to 12 months. We leave our EPS estimates for FY26-27 unchanged, but increase our price target to 22x FY27 EPS. Our previous target was based on 20x FY26 EPS, but we roll forward on a 10% higher multiple as the sentiment towards grid operators benefits from the “wall of money” into datacenters, while grid connection is the bottleneck. It can take years before the ROE ...
- Hilde Van Boxstael
- Lynn Hautekeete
- Thomas Couvreur
- Wim Lewi
- Thomas Couvreur
ING Increased estimates, but sector re-rate as main driver
Over the last few quarters ING's share price has appreciated significantly, mainly on the back of multiple expansion in the European banking sector. While ING doubled in value over the past 2 years, it's share price performance and multiple expansion is in line with its European peers. We increased our FY25-FY27 estimates and land on a new SOTP valuation of €26. Without a further increase in sector valuations, additional upside for ING is limited. We reiterate our Accumulate rating.
- Guy Sips
Biotalys Ending collaboration with Novonesis, new partnership with 21s...
Biotalys has entered into a strategic partnership with 21st.BIO to accelerate the production of Biotalys' protein-based biocontrol solutions. Biotalys indicated that this collaboration will leverage 21st.BIO's proprietary fermentation platform to support the production of Biotalys' AGROBODY agricultural biocontrol products at commercially competitive costs. We regret that Biotalys and Novonesis will conclude their collaboration (in line with the transition to this new agreement). Biotalys will...
- Guy Sips
- Hilde Van Boxstael
- Mathijs Geerts Danau
- Thomas Couvreur
- Wim Lewi
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.